Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন*
Indications:
-
Treatment of type 1 diabetes mellitus
-
Treatment of type 2 diabetes mellitus requiring long-acting basal insulin
-
Used for maintaining steady blood glucose control
Pharmacology:
ABASAGLAR KwikPen contains insulin glargine, a long-acting basal insulin analog that provides a constant insulin level over 24 hours, reducing glucose production and helping maintain blood sugar stability.
Dosage:
-
Individualized dosing based on blood glucose monitoring
-
Typically administered once daily subcutaneously
-
Dose adjustments depend on diet, exercise, and blood sugar readings
Administration:
-
Prefilled pen for subcutaneous injection in abdomen, thigh, or upper arm
-
Convenient and easy-to-use with dose dial
-
Rotate injection sites to prevent lipodystrophy
Interaction:
-
Can interact with other diabetes medications, beta-blockers, corticosteroids
-
Alcohol and certain drugs may affect blood sugar control and insulin requirements
Contraindications:
-
Known hypersensitivity to insulin glargine or any component of the pen
-
Hypoglycemia or low blood sugar episodes
Side Effects:
-
Hypoglycemia (most common adverse effect)
-
Injection site reactions such as redness, swelling
-
Allergic reactions including rash, itching, and rare anaphylaxis
-
Possible weight gain
Pregnancy & Lactation:
-
Use only if clearly needed during pregnancy, with medical supervision
-
Considered compatible with breastfeeding under doctor's advice
Precautions & Warnings:
-
Regular glucose monitoring essential to avoid hypo- or hyperglycemia
-
Do not share pens or needles
-
Use caution in patients with kidney or liver dysfunction
Therapeutic Class:
Antidiabetic Agents, Insulin, Long-acting Insulin Analog
Storage Conditions:
-
Store unopened pens refrigerated at 2°C to 8°C
-
Do not freeze
-
After first use, store at room temperature below 30°C for up to 28 days
-
Protect from heat and light exposure
.jpg)
.jpg)
Change Language